Clinical Trials Browser

Phase 1/2 × OTHER × Monatide (IMS 3015) × Clear all

NCT04106115 2024-12-04

DURANCE

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01308294 2020-06-11

LAG-3/IMP321

Phase 1/2 Terminated

16 enrolled 12 charts

Melanoma

NCT01079741 2018-02-13

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Phase 1/2 Completed

34 enrolled 10 charts

Melanoma, Neoplasms, Skin Neoplasms, Carcinogenesis